<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen L</submitter><funding>National Grant Program on Key Infectious Disease</funding><funding>International Cooperation Project of Guangzhou Science and Technology Program</funding><pagination>483-495</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6373280</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>164(2)</volume><pubmed_abstract>Restoring antiviral immunity is a promising immunotherapeutic approach to the treatment of chronic hepatitis B virus (HBV) infection. Dendritic cells play a crucial role in triggering antiviral immunity. In this study, we identified immunodominant epitopes prevalent in CD8&lt;sup>+&lt;/sup> T cell responses. We characterized the hierarchy of HBV epitopes targeted by CD8&lt;sup>+&lt;/sup> T cells following autologous monocyte-derived dendritic cell (moDC) expansion in HBV-infected subjects with distinct disease stages: treatment-naïve (TN group, n = 168), treatment with complete virological response (TR group, n = 72), and resolved HBV infection (RS group, n = 28). T cell responses against 32 HBV epitopes were measured upon moDC expansion. Several subdominant epitopes that triggered HBV-specific CD8&lt;su</pubmed_abstract><journal>Archives of virology</journal><pubmed_title>A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion.</pubmed_title><pmcid>PMC6373280</pmcid><funding_grant_id>2016201604030021</funding_grant_id><funding_grant_id>2014ZX10002002-002</funding_grant_id><pubmed_authors>Lai J</pubmed_authors><pubmed_authors>Cao H</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Lian Y</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Shu X</pubmed_authors><pubmed_authors>Stamataki Z</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors></additional><is_claimable>false</is_claimable><name>A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion.</name><description>Restoring antiviral immunity is a promising immunotherapeutic approach to the treatment of chronic hepatitis B virus (HBV) infection. Dendritic cells play a crucial role in triggering antiviral immunity. In this study, we identified immunodominant epitopes prevalent in CD8&lt;sup>+&lt;/sup> T cell responses. We characterized the hierarchy of HBV epitopes targeted by CD8&lt;sup>+&lt;/sup> T cells following autologous monocyte-derived dendritic cell (moDC) expansion in HBV-infected subjects with distinct disease stages: treatment-naïve (TN group, n = 168), treatment with complete virological response (TR group, n = 72), and resolved HBV infection (RS group, n = 28). T cell responses against 32 HBV epitopes were measured upon moDC expansion. Several subdominant epitopes that triggered HBV-specific CD8&lt;su</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Feb</publication><modification>2026-07-16T19:55:15.338Z</modification><creation>2026-07-12T03:08:37.932Z</creation></dates><accession>S-EPMC6373280</accession><cross_references><pubmed>30415392</pubmed><doi>10.1007/s00705-018-4095-0</doi></cross_references></HashMap>